• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

88.40 -0.08 (-0.09%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 510,361
Open 89.00
Bid (Size) 85.00 (100)
Ask (Size) 89.00 (100)
Prev. Close 88.48
Today's Range 86.14 - 90.99
52wk Range 32.21 - 170.87
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
September 09, 2026
From GeneDx
Via Business Wire
News headline image
GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree
September 01, 2026
From GeneDx
Via Business Wire

Performance

YTD
-33.2%
-33.2%
1 Month
-0.9%
-0.9%
3 Month
+27.9%
+27.9%
6 Month
+48.3%
+48.3%
1 Year
-24.6%
-24.6%

More News

Read More
News headline image
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
August 24, 2026
From GeneDx
Via Business Wire
GeneDx Holdings (NASDAQ:WGS) Beats Q2 Revenue Estimates and Swings to Adjusted Profit ↗
August 03, 2026
Via Chartmill
News headline image
GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
August 11, 2026
From GeneDx
Via Business Wire
News headline image
GeneDx (WGS) Q2 2026 Earnings Call Transcript ↗
August 10, 2026
Via The Motley Fool
Topics Earnings
News headline image
GeneDx to Participate in Upcoming Investor Conferences
August 06, 2026
From GeneDx
Via Business Wire
News headline image
GeneDx Q2 Earnings Call Highlights ↗
August 03, 2026
Via MarketBeat
Topics Earnings
News headline image
GeneDx Reports Second Quarter 2026 Financial Results
August 03, 2026
From GeneDx
Via Business Wire
News headline image
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026
August 03, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with SBS Law
August 03, 2026
From Schall Law
Via GlobeNewswire
News headline image
GeneDx Holdings Corp. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against GeneDx Holdings Corp. - WGS
July 31, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
GENEDX HOLDINGS DEADLINE MONDAY AUGUST 3rd: Bragar Eagel & Squire, P.C. Urges GeneDx Holdings Corp. Investors to Contact the Firm Regarding Lead Plaintiff Deadline
July 31, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
July 31, 2026
Via Newsfile
Topics Fraud Lawsuit
News headline image
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS
July 30, 2026
From SkyMedia, LLC
Via GlobeNewswire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
July 29, 2026
Via Newsfile
Topics Fraud Lawsuit
News headline image
WGS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026
July 29, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
July 28, 2026
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS
July 28, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
GENEDX HOLDINGS DEADLINE AUGUST 3rd: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the Firm
July 27, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
July 27, 2026
Via Newsfile
Topics Fraud Lawsuit
News headline image
GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
July 27, 2026
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
July 24, 2026
Via Newsfile
Topics Fraud Lawsuit
News headline image
WGS Deadline: Rosen Law Firm Urges GeneDx Holdings Corp. (NASDAQ: WGS) Stockholders to Contact the Firm for Information About Their Rights
July 23, 2026
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS
July 23, 2026
From SkyMedia, LLC
Via GlobeNewswire

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 88.40
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 09/25/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap